Stay updated on IPI-145 Plus FCR in CLL Clinical Trial

Sign up to get notified when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IPI-145 Plus FCR in CLL Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page otherwise remains a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T11:17:26.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A notice about NIH website terminology appears above the page, while the study content area displays a 403 Forbidden message instead of the clinical trial record.
    Difference
    2%
    Check dated 2026-10-25T11:20:21.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T12:14:58.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1, while the study record remains inaccessible on a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T13:24:52.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the usual content. The page shows a standard error layout with navigation and footer, indicating access is blocked.
    Difference
    20%
    Check dated 2026-09-20T22:26:23.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6. This reflects a new build/version of the page; no visible content or functional changes are introduced.
    Difference
    0.1%
    Check dated 2026-08-30T15:53:11.000Z thumbnail image

Stay in the know with updates to IPI-145 Plus FCR in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.